Moderna, Inc. (ETR:0QF)
22.15
-0.93 (-4.01%)
At close: Aug 25, 2025, 5:30 PM CET
Moderna Revenue
Moderna had revenue of $142.00M USD in the quarter ending June 30, 2025, a decrease of -41.08%. This brings the company's revenue in the last twelve months to $3.08B, down -39.05% year-over-year. In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%.
Revenue (ttm)
$3.08B
Revenue Growth
-39.05%
P/S Ratio
3.15
Revenue / Employee
$530.69K
Employees
5,800
Market Cap
8.25B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.18B |
Moderna News
- 2 days ago - Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' - Benzinga
- 2 days ago - 30 Stocks That Could Rally 30% or More - Kiplinger
- 5 days ago - Moderna Stock Is Trading Higher Friday: What's Going On? - Benzinga
- 5 days ago - Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 - Wallstreet:Online
- 5 days ago - Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 - Accesswire
- 6 days ago - Moderna to Present at Upcoming Conferences in September 2025 - Accesswire
- 6 days ago - Moderna to Present at Upcoming Conferences in September 2025 - Wallstreet:Online
- 12 days ago - Short bets on S&P 500 Healthcare sector ease in July; Moderna remains most heavily shorted stock - Seeking Alpha